News from pharmaxis A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 27, 2012, 03:00 ET Pharmaxis recibe la aprobación para la comercialización de Bronchitol en la UE

La compañía farmacéutica Pharmaxis (ASX: PXS) se complace en anunciar que ha recibido la Autorización de la Comisión Europea para la comercialización ...


Apr 27, 2012, 03:00 ET Pharmaxis obtient l'autorisation de mise sur le marche de Bronchitol dans l'Union Europeenne

Les laboratoires pharmaceutiques Pharmaxis (ASX : PXS) sont ravis d'annoncer aujourd'hui avoir obtenu l'autorisation de mise sur le marché (AMM) de...


Apr 27, 2012, 03:00 ET Pharmaxis riceve l'approvazione alla commercializzazione di Bronchitol in Europa

L'azienda farmaceutica Pharmaxis (ASX: PXS) è lieta di annunciare di aver ottenuto dalla Commissione Europea l'autorizzazione all'immissione in...


Oct 24, 2011, 08:56 ET Pharmaxis Announces Major Milestone: Positive Bronchitol Opinion for Europe

Pharmaceutical company Pharmaxis (ASX: PXS) today announced the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion...


Nov 10, 2010, 05:31 ET Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology

Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for respiratory and immune disorders, will present ARIDOL™...


Oct 22, 2010, 12:22 ET Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results

Pharmaceutical company Pharmaxis (ASX: PXS) today announced significant results of pooled data from its two large scale six month Phase III trials of ...


Oct 06, 2010, 01:13 ET FDA Approves Pharmaxis' ARIDOL™ (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness

Pharmaxis, a global specialty pharmaceutical company focused on therapeutic products for chronic respiratory and immune disorders, announced today...